Piper Sandler Releases a Buy Rating on Beyond Air (XAIR)
Piper Sandler analyst Jason Bednar assigned a Buy rating to Beyond Air (XAIR – Research Report) today and set a price target of $1.00.
Masimo Co. (NASDAQ:MASI) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...
Business Insider1d
BTIG Keeps Their Hold Rating on Beyond Air (XAIR)
Thibault covers the Healthcare sector, focusing on stocks such as Masimo, Abbott Laboratories ... Beyond Air (XAIR) Company Description: Beyond Air, Inc. is a clinical-stage medical device and ...
Greenwich Time6d
Greenwich Hospital's Smilow gets new medical director and other celebrations
Dr. William K. Oh has been appointed as medical director of Smilow Cancer Hospital at Greenwich Hospital, as well as director ...